Research and analysis

Measles: post-exposure prophylaxis

Analysis of the effectiveness of intra-muscular human normal immunoglobulin (HNIG) for measles prophylaxis.

Document

Post-exposure measles prophylaxis

This file may not be suitable for users of assistive technology. Request a different format.

If you use assistive technology and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Detail

This report considers the effectiveness of human normal immunoglobulin (HNIG) as a prophylaxis after exposure to measles in certain groups including:

  • patients with weakened immune systems
  • pregnant women
  • children